According to Avadel Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -22.75%. At the end of 2020 the company had an Operating Margin of -22.75%.
Year | Operating Margin | Change |
---|---|---|
2020 | -22.75% | -65.08% |
2019 | -65.16% | -40.56% |
2018 | -109.61% | -304.94% |
2017 | 53.48% | -926.91% |
2016 | -6.47% | -114.29% |
2015 | 45.26% | -107.4% |
2014 | -611.38% | 153.65% |
2013 | -241.03% | 693.34% |
2012 | -30.38% | 15.41% |
2011 | -26.33% | 11.4% |
2010 | -23.63% | -12.99% |
2009 | -27.16% | -43.49% |
2008 | -48.06% | -55.32% |
2007 | -107.58% | -33.64% |
2006 | -162.12% | 20.82% |
2005 | -134.18% | -899.6% |
2004 | 16.78% | -205.66% |
2003 | -15.88% | -219.22% |
2002 | 13.32% | -160.96% |
2001 | -21.85% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -36.36% | 59.82% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -8,391.15% | 36,784.18% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.